The number of people living with undiagnosed HIV is increasing in the WHO European Region. According to data published today by ECDC and the WHO/Europe, more than 136 000 people were newly diagnosed in 2019 – roughly 20% of these were diagnosed in the EU/EAA and 80% in the eastern part of the European Region. Every second HIV diagnosis (53%) happens at a late stage of the infection, when the immune system has already started to fail. This is a sign that testing strategies in the Region are not working properly to diagnose HIV early.
The European Centre for Disease Prevention and Control (ECDC) is today opening the 2020 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE). A key theme at the ESCAIDE conference is COVID-19, with two plenaries that will focus on the epidemiology, societal impact and effectiveness of measures taken with respect to the pandemic.
On 18 November 2020, the 11th outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) was declared over. There have been 130 cases, including 55 deaths reported from 13 health zones in the Equateur Province since the beginning of the outbreak almost six months ago.
Rapid Risk Assessment: Increase in fatal cases of COVID-19 among long-term care facility residents in the EU/EEA and the UK
This risk assessment details the latest epidemiological data in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) with a focus on older age groups and national reports of outbreaks among residents of LTCFs. All EU/EEA countries and the UK have experienced outbreaks among LTCF residents since August 2020.
Antimicrobial resistance and consumption remains high in the EU/EEA and the UK, according to new ECDC data
New data released today by ECDC show that levels of antimicrobial resistance and antimicrobial consumption in the EU/EEA and the UK are still of concern, particularly in the southern and eastern parts of Europe.
This assessment considers the risk to human health posed by SARS-CoV-2 mink related variants. It is based on information available to ECDC at the time of publication and, unless otherwise stated, the assessment of risk refers to the risk that existed at the time of writing.
The European Commission today presented a set of proposals to expand the legal mandate of ECDC. First, a draft Regulation changing ECDC’s current founding Regulation was announced.
ECDC will assess the human implications of an extensive spread of SARS-CoV-2 in mink farms in Denmark, where by 3 November 197 farms had been affected in the country.
Rapid Risk Assessment: Increased transmission of COVID-19 in the EU/EEA and the UK – thirteenth update
In this update, we assess the risk for the general population and vulnerable individuals in relation to the increase in COVID-19 notification rates in the EU/EEA and the UK.
Rapid outbreak assessment: Multi-country outbreak of Salmonella Typhimurium and S. Anatum infections linked to Brazil nuts
Since 1 August 2019, a multi-country outbreak, caused by Salmonella Typhimurium ST19 and S. Anatum ST64, has affected three European Union (EU) countries, the United Kingdom and Canada.
French authorities have reported an increased number of dengue cases in Martinique in recent months. The number of cases notified constitute the largest outbreak reported on the island in the last decade.
Looking at newer enhanced seasonal influenza vaccines: a systematic review of efficacy, effectiveness and safety
Based on a systematic literature review, ECDC assessed the efficacy, effectiveness and safety of newer and enhanced inactivated seasonal influenza (flu) vaccines among those 18 years or older. These assessed are MF59® adjuvanted, cell-based, high-dose, and recombinant haemagglutinin influenza vaccines.
ECDC has launched a free, open source interactive tool to help with the automatised early detection of public health threats using Twitter data.
EU states are being urged to step up surveillance and biosecurity measures to guard against possible new outbreaks of avian influenza this year.
Rabies is a deadly disease and endemic in over 100 countries. It causes around 59,000 human deaths annually, the vast majority in Asia and Africa. There are safe and effective human vaccines for pre- and post-exposure prophylaxis. With a prompt and proper post-exposure prophylaxis (PEP), exposed people have a survival rate close to 100%.
In this update, we analyse the risk posed to the general population, vulnerable individuals, and healthcare provision by the current increase in COVID-19 case notification rates observed in the EU/EEA and the UK.
ECDC has launched a new COVID-19 situation dashboard, providing users with a simpler, more user-friendly platform to explore the latest available COVID-19 data from Europe and worldwide.
Cases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain Reaction (PCR) test remained positive for a long period of time following the first episode of infection or whether it represents a true reinfection.
In many EU/EEA countries and the UK, an increase of COVID-19 cases is being observed following the lifting of lockdowns and the relaxation of preventive measures such as physical distancing.
The call for applications for the EU-track cohort 2021 of the ECDC Fellowship Programme is now open.